Low income (World Bank) vs Mauritius: Pneumococcal conjugate second or third-dose vaccines (PCVc)

Low income (World Bank)
68.0%
in 2025
Mauritius
98.0%
in 2025
Low income (World Bank) rank
8th
Mauritius rank
11th

Pneumococcal conjugate second or third-dose vaccines (PCVc) over time

  • Low income (World Bank)
  • Mauritius
020406080100200820162025

How they compare

Mauritius currently reports 98.0% against 68.0% in Low income (World Bank), a difference of 30.0%.

That makes Mauritius's figure about 1.4 times Low income (World Bank)'s.

The two have swapped places 2 times across 18 shared years of data; in 2008 it was Mauritius ahead.

Low income (World Bank) ranks 8th and Mauritius ranks 11th of 11 groups.

Across the 3 decades both report, Low income (World Bank) averaged higher in 1 and Mauritius in 1.

Head to head by decade

Decade Low income (World Bank) Mauritius Difference Ahead
2000s 0.0% 0.0% 0.0%
2010s 44.8% 28.7% 16.1% Low income (World Bank)
2020s 64.0% 95.0% 31.0% Mauritius

Averages of every year both report within each decade.

Frequently asked questions

Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Low income (World Bank) or Mauritius?
Mauritius, at 98.0% against 68.0% in Low income (World Bank) as of 2025.
What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Low income (World Bank) and Mauritius?
30.0%, with Mauritius ahead.
How many years of comparable data are there for Low income (World Bank) and Mauritius?
18 years are reported by both, from 2008 to 2025.
How do Low income (World Bank) and Mauritius rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
Low income (World Bank) ranks 8th and Mauritius ranks 11th of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Low income (World Bank) vs Mauritius: Pneumococcal conjugate second or third-dose vaccines (PCVc). Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 29 August 2026, from https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/low-income-world-bank/mauritius/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/pneumococcal-conjugate-second-or-third-dose-vaccines-pcvc-immunization-coverage-by-the/low-income-world-bank/mauritius/">Low income (World Bank) vs Mauritius: Pneumococcal conjugate second or third-dose vaccines (PCVc)</a> — Statizoid

About this data

Indicator
Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
206 places, 3,705 data points, 2008–2025
Last refreshed